Drug
Fulipiftide clinical trials
Also written BRM421.
Keep track of what changes. Save the fulipiftide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
5 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
BRIM Biotechnology Inc. (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses fulipiftide is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye DiseaseNot yet recruitingPhase 2BRIM Biotechnology Inc.NCT07078955Written as BRM421 Ophthalmic Solution, 0.03%
- Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic KeratitisRecruitingPhase 2BRIM Biotechnology Inc.NCT05927428Written as BRM424 Ophthalmic Solution - Dose1
- Safety and Efficacy of BRM421 for Dry Eye SyndromeCompletedPhase 2BRIM Biotechnology Inc.NCT03066219Written as BRM421
- Safety and Efficacy of BRM421 for Dry Eye Syndrome TreatmentCompletedPhase 2/3BRIM Biotechnology Inc.NCT04343287Written as BRM421
- Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.CompletedPhase 3BRIM Biotechnology Inc.NCT05695781Written as BRM421 Ophthalmic Solution
Codes
What other systems call fulipiftide · ClinicalTrials.gg INT017370
- UNII (FDA) N9MH3WI51MFULIPIFTIDEOne source FDA
- NCI Thesaurus C213409FulipiftideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | N9MH3WI51M | FULIPIFTIDE | One source FDA |
| NCI Thesaurus | C213409 | Fulipiftide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.